Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.55 |
| ▸ | NPY1R | P25929 | 9/20 | 0.55 |
| ▸ | NPY2R | P49146 | 6/20 | 0.55 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.51 |
| ▸ | F2R | P25116 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24158522 | 1.00 | NPY4R (0.55) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL24169006 | 1.00 | NPY4R (0.55) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL26079290 | 1.00 | NPY4R (0.55) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL24158528 | 1.00 | NPY4R (0.55) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL26079279 | 0.95 | NPY4R (0.49) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL24158500 | 0.95 | NPY4R (0.49) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL24158395 | 0.93 | NPY4R (0.54) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL24158508 | 0.93 | KISS1R (0.52) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL26079287 | 0.89 | KISS1R (0.56) | NPY4RNPY5RNPY1RNPY2RKISS1R | |
| SCHEMBL24158521 | 0.88 | KISS1R (0.49) | NPY4RNPY5RNPY1RNPY2RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312646-A1 | ANTIBACTERIAL PEPTIDES | Universite de Bordeaux (FR) | 2023-10-05 | — | — | US | disclosed |
| WO-2022002951-A1 | ANTIBACTERIAL PEPTIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2022-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312646-A1 | ANTIBACTERIAL PEPTIDES | VIP, NRDC, CLPP | NPY4R 3624/4885NPY5R 3629/4885NPY1R 3838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.